BamSEC and AlphaSense Join Forces
Learn More

Catalent Inc.

Formerly NYSE: CTLT

Material Contracts Filter

EX-10.1
from 8-K 4 pages [Name] via Email Dear [Name]
12/34/56
EX-10.18
from 10-K/A 7 pages August 25, 2023 David McErlane Dear David,
12/34/56
EX-10.17
from 10-K/A 6 pages June 8, 2023 Lisa Evoli Dear Lisa
12/34/56
EX-10.4 1
from 10-K 4 pages Amendment to Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 4 pages Special Retention Award Agreement
12/34/56
EX-10.3
from 10-Q 21 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Catalent
12/34/56
EX-10.3
from 10-Q 7 pages Termination Agreement (Within the Meaning of Section 7:670b(1) of the Dutch Civil Code, in Conjunction With Section 7:900 of the Dutch Civil Code)
12/34/56
EX-10.1
from 8-K 4 pages Amendment No. 1 to the Catalent, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-10.18 1
from 10-K 7 pages We Are Pleased to Offer You an International Assignment From the Netherlands to the United States With Catalent Pharma Solutions LLC. We Trust This Will Be a Mutually Beneficial Experience for You as Well as for the Company. This Letter Confirms the Terms and Conditions That Apply to Your Assignment as President, Division Head Biomodalities Based in Somerset, New Jersey. I.ASSIGNMENT Summary •home Country: The Netherlands •host Country: The United States •employer: Catalent Pharma Solutions, LLC •position Title: President, Division Head Biomodalities •manager While on Assignment: Biologics Committee (Through Its Representative, Alessandro Maselli, President & CEO) •citizenship/Permanent Resident Status: The Netherlands •annual Base Salary: US$500,000 Paid From the Netherlands as €494,218 •management Incentive Plan Target: US$400,000 Paid From the Netherlands in Local Currency •long Term Incentive Plan Target: US$650,000 •scheduled Assignment Start Date: October 17th, 2022 •scheduled Assignment End Date: November 30, 2025 •assignment Duration: Thirty-Six (36) Months •assignment Policy: International Long-Term Assignment
12/34/56
EX-10.18
from 10-K 10 pages Employment Agreement
12/34/56
EX-10.17 2
from 10-K 1 page August 14, 2023 Acknowledged: /S/ Ricky Hopson Date Aug. 15, 2023
12/34/56
EX-10.17 1
from 10-K 2 pages May 1st, 2023 Ricky Hopson Dear Ricky
12/34/56
EX-10.17
from 10-K 2 pages July 1, 2022 Ricky Hopson
12/34/56
EX-10.9 1
from 10-K 3 pages Re: Severance Benefits
12/34/56
EX-10.9
from 10-K 4 pages [Date] [Executive Name] [Executive Home Address] Re: Severance Benefits
12/34/56
EX-10.6 4
from 10-K 25 pages Performance Share Unit Agreement Under the Catalent, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-10.6 3
from 10-K 21 pages Option Agreement Under the Catalent, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-10.6 2
from 10-K 21 pages Restricted Stock Unit Agreement Under the Catalent, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-10.6 1
from 10-K 10 pages Restricted Stock Unit Agreement for Non-Employee Directors Under the Catalent, Inc. 2018 Omnibus Incentive Plan
12/34/56